Xbrane Biopharma (Sweden) Price on October 10, 2024
| XBRANE Stock | SEK 0.18 0.01 5.26% |
If you're considering investing in Xbrane Stock, it is important to understand the factors that can impact its price. As of today, the current price of Xbrane Biopharma stands at 0.18, as last reported on the 27th of November, with the highest price reaching 0.18 and the lowest price hitting 0.18 during the day. Xbrane Biopharma appears to be out of control, given 3 months investment horizon. Xbrane Biopharma shows Sharpe Ratio of 0.0588, which attests that the company had a 0.0588% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Xbrane Biopharma, which you can use to evaluate the volatility of the company. Please utilize Xbrane Biopharma's Market Risk Adjusted Performance of (0.45), mean deviation of 4.77, and Downside Deviation of 6.66 to validate if our risk estimates are consistent with your expectations.
Xbrane Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Xbrane |
Sharpe Ratio = 0.0588
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | XBRANE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.56 actual daily | 58 58% of assets are less volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Xbrane Biopharma is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xbrane Biopharma by adding it to a well-diversified portfolio.
Xbrane Biopharma Valuation on October 10, 2024
It is possible to determine the worth of Xbrane Biopharma on a given historical date. On October 10, 2024 Xbrane was worth 0.21 at the beginning of the trading date compared to the closed value of 0.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Xbrane Biopharma stock. Still, in general, we apply an absolute valuation method to find Xbrane Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Xbrane Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Xbrane Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.19 | 0.22 | 0.19 | 0.21 | 10,698,617 | |
10/10/2024 | 0.21 | 0.22 | 0.20 | 0.21 | 4,721,684 |
| 0.21 | 0.21 | 0.19 | 0.19 | 3,747,328 |
| Backtest Xbrane Biopharma | | | Xbrane Biopharma History | | | Xbrane Biopharma Valuation | Previous | Next |
Xbrane Biopharma Trading Date Momentum on October 10, 2024
| On October 11 2024 Xbrane Biopharma AB was traded for 0.19 at the closing time. The highest price during the trading period was 0.21 and the lowest recorded bid was listed for 0.19 . The volume for the day was 3.7 M. This history from October 11, 2024 contributed to the next trading day price decline. The trading price change to the next closing price was 9.52% . The trading price change to the current price is 9.52% . |
Xbrane Biopharma Fundamentals Correlations and Trends
By evaluating Xbrane Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Xbrane Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Xbrane financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Xbrane Biopharma Stock history
Xbrane Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Xbrane is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Xbrane Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Xbrane Biopharma stock prices may prove useful in developing a viable investing in Xbrane Biopharma
Xbrane Biopharma AB , a biopharmaceutical company, develops and manufactures biosimilars and generic long acting injectables. Xbrane Biopharma AB was founded in 2008 and is headquartered in Solna, Sweden. Xbrane Biopharma operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 35 people.
Xbrane Biopharma Stock Technical Analysis
Xbrane Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Xbrane Biopharma Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Xbrane Biopharma AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Xbrane Biopharma November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Xbrane Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xbrane Biopharma shares will generate the highest return on investment. By undertsting and applying Xbrane Biopharma stock market strength indicators, traders can identify Xbrane Biopharma AB entry and exit signals to maximize returns
Xbrane Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Xbrane Biopharma's price direction in advance. Along with the technical and fundamental analysis of Xbrane Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Xbrane to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0428 | |||
| Jensen Alpha | 0.3536 | |||
| Total Risk Alpha | (0.75) | |||
| Sortino Ratio | 0.0241 | |||
| Treynor Ratio | (0.46) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Xbrane Stock analysis
When running Xbrane Biopharma's price analysis, check to measure Xbrane Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xbrane Biopharma is operating at the current time. Most of Xbrane Biopharma's value examination focuses on studying past and present price action to predict the probability of Xbrane Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xbrane Biopharma's price. Additionally, you may evaluate how the addition of Xbrane Biopharma to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets |